Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer

BACKGROUND. This study explores the incidence of patient‐reported major toxicity—symptoms rated “moderate,” “severe,” or “very severe”—for chemotherapy regimens commonly used in early breast cancer. PATIENTS AND METHODS. Female patients aged 21 years or older completed a validated Patient‐Reported S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Nyrop, Kirsten A., Deal, Allison M., Shachar, Shlomit S., Basch, Ethan, Reeve, Bryce B., Choi, Seul Ki, Lee, Jordan T., Wood, William A., Anders, Carey K., Carey, Lisa A., Dees, Elizabeth C., Jolly, Trevor A., Reeder‐Hayes, Katherine E., Kimmick, Gretchen G., Karuturi, Meghan S., Reinbolt, Raquel E., Speca, JoEllen C., Muss, Hyman B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656489/
https://ncbi.nlm.nih.gov/pubmed/30552158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0590
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados